Ayer Neuroscience Institute providers are leading clinical research that will change care in the future. We have a number of clinical trials in progress across our different specialty programs open for participation. That means you might have access to cutting-edge medication, technology or therapies that would not be available to you otherwise. If you would like more information on a trial, please reach out to us at AyerNSIResearch@hhchealth.org or talk to your provider about any open research studies that may be appropriate for you.
Stroke
- Arpeggio: A study of novel neuro-protective agent for ischemic stroke patients
- Aspire: Patients with a recent ICH and high-risk non-valvular AF
- Captiva: Patients with Intracranial Vascular Atherostenosis
- Oceanic: Study of the oral FXIa inhibitor asundexian for the prevention of ischemic stroke in male and female participants 18 years and older after an acute non-cardioembolic ischemic stroke or high-risk TIA
- Saturn/Saturn MRI: Statin drug use in intracerebral hemorrhage patients
- SISTER: A phase-2, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS23.
- SleepSmart: Sleep for Stroke Management And Recovery
- STEP: A Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large or medium vessel occlusions (LVOs and MVOs).
- Tested: Treatment with Endovascular Intervention for Stroke Patients with Existing Disability
Movement Disorder
- Spanish Parkinson’s Disease Clinic: Improving the Health of Spanish Speaking Patients with Parkinson's Disease
Neurosurgery
- Vision: Visualization of the STN and GPi for DBS surgery in Patients with Parkinson's Disease
- Bia-Gen: Bia-Gen™ Bioactive Bone Graft in Posterolateral Instrumented Lumbar Fusion
- Neurogenic Stress Cardiomyopathy: patients with Aneurysmal Subarachnoid Hemorrhage
- Spine Equity Study: Short- and Long-Term Outcomes after Spine Surgery
Headache
- Shiratronics: A pivotal study evaluating safety and efficacy of the Shiratronics Migraine Therapy System in relieving, interrupting, and preventing chronic migraine (RELIEV-CM2).